Fitness5 months ago
AAV5 Gene Therapy for Severe Hemophilia A Successfully Enables FVIII Production
Findings published in Molecular Therapy examined the clinical immunogenicity outcomes of valoctocogene roxaparvovec, an adeno-associated virus serotype 5 (AAV5)–vectored gene therapy, in adults with severe hemophilia...
